A detailed history of Sanctuary Advisors, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 19,197 shares of CRMD stock, worth $217,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,197
Previous 11,526 66.55%
Holding current value
$217,693
Previous $142 Million 16.72%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Jan 13, 2026

SELL
$10.07 - $14.83 $75,414 - $111,061
-7,489 Reduced 39.01%
11,708 $136 Million
Q3 2025

Jan 06, 2026

BUY
$10.07 - $14.83 $77,246 - $113,760
7,671 Added 66.55%
19,197 $118 Million
Q2 2025

Jan 06, 2026

SELL
$5.86 - $16.56 $44,952 - $127,031
-7,671 Reduced 39.96%
11,526 $142 Million
Q1 2025

Jan 06, 2026

SELL
$6.16 - $12.57 $332 - $678
-54 Reduced 0.28%
19,197 $118 Million
Q4 2024

Jan 31, 2025

BUY
$8.1 - $13.59 $56 - $95
7 Added 0.04%
19,251 $211 Million
Q3 2024

Nov 25, 2024

BUY
$3.64 - $8.23 $70,048 - $158,378
19,244 New
19,244 $192 Million

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $467M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Sanctuary Advisors, LLC Portfolio

Follow Sanctuary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanctuary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanctuary Advisors, LLC with notifications on news.